Aberrant Glycosylation Promotes Pancreatic Inflammation
Ontology highlight
ABSTRACT: CA19-9 is a glycan elevated in human gastrointestinal pathologies, but absent from rodents. We humanized the mouse glycome and found that CA19-9 is not only a correlative biomarker of pancreatic disease, but also plays a causative role in the initiation of pancreatitis. Elevation of CA19-9 results in the activation of EGFR signaling in the normal pancreatic ductal compartment through secretion of Fibulin 3. These signaling changes can be blocked by blocking either CA19-9 or Fibulin 3.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Mus Musculus (mouse)
SUBMITTER: Keith Rivera
LAB HEAD: David Tuveson
PROVIDER: PXD008564 | Pride | 2019-06-06
REPOSITORIES: Pride
ACCESS DATA